The Oxford ICSB brings together members of CFSAN/FDA, government officials, Academic researchers, major trade associations and industry representative discussing approaches for post market surveillance, risk and safety assessment, quality control and adverse event reporting (AER) for botanical dietary supplements (BDS) and natural products, as well as regulatory aspects and other pressing topics that affect BDSs and their impact on consumers.
Stakeholders interested in submitting abstracts for consideration may use the following link: http://oxfordicsb.org/Abstracts/ . The deadline for abstract submissions is December 16th, 2019.
Registration for the 2020 conference is also open as well with early bird register rates available until January 15th. You can register through our CVent page at http://www.cvent.com/d/qhq8t7/4W